STAAR Surgical Average Price Target Cut to $28.14
Analysts lowered the average 12-month price target for STAAR Surgical shares from $29.25 to $28.14. The consensus rating remains at Hold.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to estimates from seven analysts, the average 12-month price target for STAAR Surgical shares fell from $29.25 to $28.14. Forecasts range from $19 to $34 per share.
According to TradingView, citing FactSet data, the updated target implies roughly 16% potential upside from the November 20 closing price. The consensus rating remains Hold across nine covering analysts: two Buys, six Holds and one Sell.
why it matters
Routine target revisions like this typically matter only to investors following the company closely and rarely have a meaningful effect on the broader market.
tags
instruments
sources
- STAAR Surgical Company Stock 12‑Month Price Target Cut to $28.14, Implies 16% Upside — TradingView, 21 November 2026 at 04:20 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗